Class 1.1 new drugs declared for clinical use in 2014 (as of October)
-
Last Update: 2014-11-11
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
It involves 50 enterprises or institutions - 46 enterprises and 4 research institutions Most enterprises or institutions have declared one variety (one API and one preparation in total), and only six enterprises have declared two or more varieties (among which, the API and preparation declared by hausen are in two different enterprises) Hengrui pharmaceutical and Zhaoke pharmaceutical, which have the largest number of declared varieties, all have declared three varieties for clinical application This year, only one of the clinical varieties has been approved (mehuatinib of Huadong medicine), one is under approval (imitavir phosphate of dongyangguang), and the rest are all in "under review" status Class 1.1 new drugs declared for clinical application in 2014 (as of October) number of varieties declared by enterprises Hengrui medicine 3 Shr6390 \ shr6390 tablets, shr4640 \ shr4640 tablets, shr3680 \ shr3680 tablets Zhaoke pharmaceutical 3 A total of 4 cases of sprpvastatin, 4\, thymosin beta, thymosin beta 2 eye drops, Sheng Fa peptide, Sheng Fa peptide eye drops, Sheng Fa peptide spray, Hong Chong medicine (hausen) 2 HS-10234, Haosen pharmaceutical 2 hs-10234 tablets, hs-10220 capsules, 2 isothiafludine dry suspension, Shanghai Institute of medicine, Chinese Academy of Sciences, tpn171h tablets Dongyangguang Pharmaceutical Co., Ltd new medicine of imitrevir 2 phosphate / imitrevir phosphate capsule, lalotinib mesylate / lalotinib mesylate capsule 1 CM118 \ CM118 pianxuanzhu medicine 1 jiaglijing \ jiaglijing pianshunjian biology 1 ketamine / ketamine capsules 1 polyethylene glycol irinotecan / polyethylene glycol irinotecan for injection Hispec 1 hsk3486 \ hsk3486 emulsion injection Tianjin Pharmaceutical Research Institute 1 zhifeisaban \ zhifeisaban tablets Changao pharmaceutical 1 oglitaine hydrochloride \ oglitaine hydrochloride tablet Xianju pharmaceutical 1 olmecxone sodium \ olmecxone sodium for injection Shenghe pharmaceutical 1 c118p \ c118p celestine 1 ct-707 \ ct-707 granules for injection Zhendong pharmaceutical 1 lalotasil / lalotasil lipid microsphere injection Beijing Institute of tumor prevention and treatment 1 Angiogenin \ angiogenin for injection magpie medicine 1 Nitrazine \ Nitrazine for injection Taijing medicine 1 Injection of bromine, PL-5, antibacterial peptide PL-5, antimicrobial peptide PL-5, Heyuan Pharmaceutical Co., Ltd 1 hyc11395 \ hyc11395 ciweier 1 cvi-lm001 \ cvi-lm001 tablet for injection 1 RX108\RX108 injection Xin Chen Tai Fei Er 1 bromo hydrochloride hydrochloride bromine amine spray, Baiji Shenzhou 1 bgb-283 \ bgb-283 capsule 1 tpn171h humanwell pharmaceutical 1 remazolam besylate \ remazolam besylate for injection 1 ditinilta \ 1 clotrime (fg-4592) for injection \ clotrime capsule (fg-4592) Geli biological 1 asc08 \ asc08 tablets Haikou Pharmaceutical Factory 1 flufenidone \ flufenidone capsule Synthetic pharmaceutical 1 disodium levonoconazole phosphate \ disodium levonoconazole phosphate for injection Ceftoren sodium \ ceftoren sodium phosphate for injection purunol 1 beretinib \ beretinib enteric coated capsule Zhongqi pharmaceutical 1 Sklb1028 \ sklb1028 capsule Huahai pharmaceutical 1 hydroxypiperone hydrochloride \ hydroxypiperone hydrochloride tablets East China Medicine 1 mehuatini / mehuatini tablet Haizheng pharmaceutical 1 peg-sn38 \ peg-sn38 for injection Shenyang Pharmaceutical University 1 Mitoxantrone Hydrochloride Injection for lymphotracer to develop pharmaceutical industry 1 prochlorazine / prochlorazine tablets Enhua pharmaceutical 1 dp-vpa \ dp-vpa tablet Beida pharmaceutical 1 bpi-9016m \ bpi-9016m tablet Changtai pharmaceutical 1 sodium pyruvate \ sodium pyruvate inhaler Ruixing gene 1 f573 \ f573 for injection Yuandong Pharmaceutical Co., Ltd Changshan biochemical 1 ibuprofen \ ibuprofen injection Henry medicine 1 amoquini \ amoquini capsule New health sector, but there are omissions, please fill in the message!
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.